NTLA Cost of Revenue

Intellia Therapeutics Inc · Cost of Revenue

NTLA logo

NTLA Cost of Revenue

Latest reported$87.17M
NTLA Cost of Revenue ($1.66M → $87.17M)
High-resolution chart · PNG

NTLA cost of revenue history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Intellia Therapeutics Inc Cost of Revenue — Annual fiscal periods (USD)
Period endingCost of Revenue (USD)
15,923,000
10,285,000
8,976,000
7,572,000
6,891,000
150,408,000
108,413,000
89,115,000
67,647,000
31,840,000
11,170,000
1,657,500
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.